Shopping Cart 0
Cart Subtotal
USD 0

McKesson Corp (MCK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

McKesson Corp (McKesson) is a provider of healthcare services and information technology solutions. It distributes pharmaceuticals, medical equipment, and health and beauty care products in North America and overseas. The company also develops and provides decision support software and systems to assist clinicians and physicians in clinical diagnosis and treatment. McKesson offers medicines, pharmaceutical solutions, information and care management products and services to pharmacies and institutional providers including hospitals and health systems. It also offers products and services to the alternative site market such as physician offices, surgery centers, long-term care facilities and home care businesses. It has operations in various countries including the US, the UK, Canada, Barbados, Bermuda, Germany, and Ireland. McKesson is headquartered in California, the US.

McKesson Corp (MCK)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

McKesson Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

McKesson Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

McKesson Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

McKesson Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

McKesson Corp, Medical Devices Deals, 2012 to YTD 2018 10

McKesson Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

McKesson Corp, Pharmaceuticals & Healthcare, Deal Details 13

Asset Purchase 13

Sanova Pharma to Acquire Okopharm, Okomed and BasoVital Products from Okopharm 13

Lloyds Pharmacy to Acquire Pharmacy Business from J Sainsbury for USD194.7 Million 14

Private Equity 15

New Mountain Capital Acquires Medical Specialties Distributors From Water Street Healthcare Partners 15

Penta Investments Receives Regulatory Approval To Acquire Lekarny Lloyds And Gehe Pharma From Celesio For USD 104 Million 16

Partnerships 18

Novocure Enters into Agreement with US Oncology Research 18

Epizyme Enters into Partnership with US Oncology Research 19

Genocea Biosciences Enters into Agreement with US Oncology Research 20

BTG International Enters into Agreement with Biologics 21

McKesson Specialty Health Collaborates with Oncologists to Develop New Oncology-Specific iKnowMed Generation 2 22

ValueOptions Enters Into Agreement With McKesson 23

Pfizer Enters Into Co-Marketing Agreement With Biologics For Inlyta 24

Debt Offering 25

Celesio Completes Private Placement Of Bonds Due 2016 For USD 453 Million 25

Acquisition 26

McKesson Acquires Vantage Oncology and Biologics for USD1.2 Billion 26

Cintas to Acquire ZEE Medical from McKesson for USD130 Million 28

Celesio Acquires Remaining 40% Stake in Oncoprod 29

McKesson Completes Acquisition Of Celesio For USD 8.49 Billion 30

Elliott Management Acquires Additional Stake In Celesio 32

McKesson Acquires Med3000, Provider Of Healthcare Management Services 33

Franz Haniel Sells 4.6% Stake In Celesio For USD 129.6 Million 34

McKesson To Acquire Emendo, Healthcare IT Company 35

Zur Rose Acquires DocMorris From Celesio For USD 32.4 Million 36

Owens & Minor Completes Acquisition Of Movianto From Celesio For USD 158 Million 37

Celesio Completes Acquisition Of Remaining 49.9% Stake In Panpharma For USD 341 Million 38

McKesson Acquires Provider Of Medical Imaging Work-flow Solutions, peerVue 39

McKesson Corp-Key Competitors 40

McKesson Corp-Key Employees 41

McKesson Corp-Locations And Subsidiaries 42

Head Office 42

Other Locations & Subsidiaries 42

Recent Developments 46

Financial Announcements 46

Jul 26, 2018: McKesson Reports Fiscal 2019 First-Quarter Results 46

Jun 28, 2018: McKesson Reaffirms Fiscal 2019 Guidance and Provides Preliminary Guidance for the First Quarter 48

May 24, 2018: McKesson Reports Fiscal 2018 Fourth-Quarter and Full-Year Results 49

Jul 27, 2017: McKesson reports lower Q1 net income, updates outlook for fiscal 2018 52

Corporate Communications 53

Jul 31, 2018: McKesson Appoints Brian Tyler as President and Chief Operating Officer 53

Jul 09, 2018: The US Oncology Network Welcomes Breast Surgeon Dr. Loren Rourke to a New Role as Chief Surgical Officer 54

Legal and Regulatory 55

Aug 15, 2017: City of Birmingham and Legal Counsel Baron & Budd, Greene Ketchum, Levin Papantonio File Suit Against Pharmaceutical Distributors for Role in Creating Opioid Crisis 55

Government and Public Interest 56

Dec 04, 2017: McKesson RxO Team Identifies Five Health System Pharmacy Trends to Watch in 2018 56

Nov 02, 2017: US Oncology Research Annual Science Forum Focuses on Advances in Clinical Research, Enabling Promising New Treatments for Patients in the Community Setting 58

Product News 59

Apr 25, 2017: US Oncology Research Enrolls 2,900 Patients in Leading-Edge Clinical Trials in Twelve Months 59

Other Significant Developments 60

Sep 12, 2018: Health Mart launches National 'Power Your Partnerships' Series 60

Jul 11, 2018: McKesson ideaShare Exhibitors Donate to Nevada Childhood Cancer Foundation 61

Apr 04, 2018: McKesson Specialty Health And CoverMyMeds Launch ExpressCoverage, Integrated eServices Platform Designed To Improve Patient Care Journey 62

Mar 29, 2018: McKesson Announces New Initiatives, Launches Foundation to Help Fight Nation's Opioid Epidemic 63

Oct 31, 2017: McKesson Recommends Quick Federal Action on Key Opioid Solution Ideas 65

Oct 23, 2017: Health Mart and APCI Celebrate Pharmacists on Florida Independent Pharmacy Day 66

Feb 06, 2017: Value-based Care Services Provider, ACO Partner, Gains Traction in Arizona 67

Feb 02, 2017: McKesson Specialty Health and The US Oncology Network to Showcase Value-Based Care Expertise During Cancer Center Business Summit 69

Feb 01, 2017: Southern Cancer Center Joins The US Oncology Network 70

Jan 26, 2017: Vantage Oncology's 50 Centers and More Than 350 Affiliated Physicians Join The US Oncology Network 71

Appendix 72

Methodology 72

About GlobalData 72

Contact Us 72

Disclaimer 72


List Of Figure

List of Figures

McKesson Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

McKesson Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

McKesson Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

McKesson Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

McKesson Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

McKesson Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

McKesson Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

McKesson Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

McKesson Corp, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

McKesson Corp, Pharmaceuticals & Healthcare, Key Facts, 2018 2

McKesson Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

McKesson Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

McKesson Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

McKesson Corp, Deals By Therapy Area, 2012 to YTD 2018 9

McKesson Corp, Medical Devices Deals, 2012 to YTD 2018 10

McKesson Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Sanova Pharma to Acquire Okopharm, Okomed and BasoVital Products from Okopharm 13

Lloyds Pharmacy to Acquire Pharmacy Business from J Sainsbury for USD194.7 Million 14

New Mountain Capital Acquires Medical Specialties Distributors From Water Street Healthcare Partners 15

Penta Investments Receives Regulatory Approval To Acquire Lekarny Lloyds And Gehe Pharma From Celesio For USD 104 Million 16

Novocure Enters into Agreement with US Oncology Research 18

Epizyme Enters into Partnership with US Oncology Research 19

Genocea Biosciences Enters into Agreement with US Oncology Research 20

BTG International Enters into Agreement with Biologics 21

McKesson Specialty Health Collaborates with Oncologists to Develop New Oncology-Specific iKnowMed Generation 2 22

ValueOptions Enters Into Agreement With McKesson 23

Pfizer Enters Into Co-Marketing Agreement With Biologics For Inlyta 24

Celesio Completes Private Placement Of Bonds Due 2016 For USD 453 Million 25

McKesson Acquires Vantage Oncology and Biologics for USD1.2 Billion 26

Cintas to Acquire ZEE Medical from McKesson for USD130 Million 28

Celesio Acquires Remaining 40% Stake in Oncoprod 29

McKesson Completes Acquisition Of Celesio For USD 8.49 Billion 30

Elliott Management Acquires Additional Stake In Celesio 32

McKesson Acquires Med3000, Provider Of Healthcare Management Services 33

Franz Haniel Sells 4.6% Stake In Celesio For USD 129.6 Million 34

McKesson To Acquire Emendo, Healthcare IT Company 35

Zur Rose Acquires DocMorris From Celesio For USD 32.4 Million 36

Owens & Minor Completes Acquisition Of Movianto From Celesio For USD 158 Million 37

Celesio Completes Acquisition Of Remaining 49.9% Stake In Panpharma For USD 341 Million 38

McKesson Acquires Provider Of Medical Imaging Work-flow Solutions, peerVue 39

McKesson Corp, Key Competitors 40

McKesson Corp, Key Employees 41

McKesson Corp, Other Locations 42

McKesson Corp, Subsidiaries 42

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

McKesson Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.